Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Larcher

Showing results (261-270 of 335) with videos related to

Pageof 34
Sort By:
Urologic Oncology|November 30, 2024
Exploring the effect of patient characteristics on the association between warm ischemia time and the risk of postoperative acute kidney injury after partial nephrectomyPietro Scilipoti, Giuseppe Rosiello, Federico Belladelli, et al.
Cancers|April 13, 2023
PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage TreatmentLorenzo Bianchi, Francesco Ceci, Eleonora Balestrazzi, et al.
Minerva Urology and Nephrology|September 25, 2024
Balancing oncological control and renal function: the emerging role of robotic distal ureterectomy in upper tract urothelial carcinomaFederico Piramide, Fabrizio DI Maida, Carlo A Bravi, et al.
European Urology Focus|July 18, 2020
Head to Head Impact of Margin, Ischemia, Complications, Score Versus a Novel Trifecta Score on Oncologic and Functional Outcomes After Robotic-assisted Partial Nephrectomy: Results of a Multicenter SeriesUmberto Anceschi, Maria Consiglia Ferriero, Gabriele Tuderti, et al.
Urology|December 15, 2019
Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging CriteriaZachary A Hamilton, Umberto Capitanio, Deepak Pruthi, et al.
Minerva Urology and Nephrology|July 24, 2024
If not now, then when? The need for new evidence in the robotic management of upper tract urothelial carcinomaFabrizio DI Maida, Carlo A Bravi, Ruben DE Groote, et al.
Andrology|August 19, 2021
Testosterone in males with COVID-19: A 7-month cohort studyAndrea Salonia, Marina Pontillo, Paolo Capogrosso, et al.
BJU International|July 6, 2013
Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS projectMassimo Lazzeri, Alexander Haese, Alberto Abrate, et al.
Minerva Urology and Nephrology|November 17, 2020
Robot-assisted partial nephrectomy: 7-year outcomesUmberto Carbonara, Giuseppe Simone, Umberto Capitanio, et al.
World Journal of Urology|July 29, 2022
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progressionDaniele Cignoli, Giuseppe Fallara, Francesca Aleotti, et al.
Pageof 34

Showing results (261-270 of 335) with videos related to

Sort By:
Pageof 34
Urologic Oncology|November 30, 2024
Exploring the effect of patient characteristics on the association between warm ischemia time and the risk of postoperative acute kidney injury after partial nephrectomyPietro Scilipoti, Giuseppe Rosiello, Federico Belladelli, et al.
Cancers|April 13, 2023
PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage TreatmentLorenzo Bianchi, Francesco Ceci, Eleonora Balestrazzi, et al.
Minerva Urology and Nephrology|September 25, 2024
Balancing oncological control and renal function: the emerging role of robotic distal ureterectomy in upper tract urothelial carcinomaFederico Piramide, Fabrizio DI Maida, Carlo A Bravi, et al.
European Urology Focus|July 18, 2020
Head to Head Impact of Margin, Ischemia, Complications, Score Versus a Novel Trifecta Score on Oncologic and Functional Outcomes After Robotic-assisted Partial Nephrectomy: Results of a Multicenter SeriesUmberto Anceschi, Maria Consiglia Ferriero, Gabriele Tuderti, et al.
Urology|December 15, 2019
Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging CriteriaZachary A Hamilton, Umberto Capitanio, Deepak Pruthi, et al.
Minerva Urology and Nephrology|July 24, 2024
If not now, then when? The need for new evidence in the robotic management of upper tract urothelial carcinomaFabrizio DI Maida, Carlo A Bravi, Ruben DE Groote, et al.
Andrology|August 19, 2021
Testosterone in males with COVID-19: A 7-month cohort studyAndrea Salonia, Marina Pontillo, Paolo Capogrosso, et al.
BJU International|July 6, 2013
Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS projectMassimo Lazzeri, Alexander Haese, Alberto Abrate, et al.
Minerva Urology and Nephrology|November 17, 2020
Robot-assisted partial nephrectomy: 7-year outcomesUmberto Carbonara, Giuseppe Simone, Umberto Capitanio, et al.
World Journal of Urology|July 29, 2022
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progressionDaniele Cignoli, Giuseppe Fallara, Francesca Aleotti, et al.
Pageof 34